154 related articles for article (PubMed ID: 1033069)
21. Enhancement of carrier-mediated transport after immunologic activation of peritoneal macrophages.
Bonventre PF; Straus D; Baughn RE; Imhoff J
J Immunol; 1977 May; 118(5):1827-35. PubMed ID: 404359
[TBL] [Abstract][Full Text] [Related]
22. Mouse factor B of the alternative pathway of complement activation. I. Purification, characterization, and functional behavior.
Bitter-Suermann D; Burger R; Brade V; Hadding U
J Immunol; 1976 Nov; 117(5 Pt.2):1799-804. PubMed ID: 993580
[TBL] [Abstract][Full Text] [Related]
23. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
Perrin LH; Lambert PH; Miescher PA
J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of immune precipitation by complement.
Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
[TBL] [Abstract][Full Text] [Related]
25. Complement activation in semi-solid medium: Insolubilization of properdin and the third component of complement (C3) in agar gels.
Ziegler JB; Watson L; Goodkofsky I; Alper CA; Lepow IH
J Immunol; 1976 Jan; 116(1):75-9. PubMed ID: 812917
[TBL] [Abstract][Full Text] [Related]
26. Biosynthesis of the first component of complement by human and guinea pig peritoneal macrophages: evidence for an independent production of the C1 subunits.
Müller W; Hanauske-Abel H; Loos M
J Immunol; 1978 Oct; 121(4):1578-84. PubMed ID: 701808
[TBL] [Abstract][Full Text] [Related]
27. Evidence for the presence of components of the alternative (properdin) pathway of complement activation in respiratory secretions.
Robertson J; Caldwell JR; Castle JR; Waldman RH
J Immunol; 1976 Sep; 117(3):900-3. PubMed ID: 956659
[TBL] [Abstract][Full Text] [Related]
28. Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation.
Schorlemmer HU; Bitter-Suermann D; Allison AC
Immunology; 1977 Jun; 32(6):929-40. PubMed ID: 328387
[TBL] [Abstract][Full Text] [Related]
29. Quantitative studies of the secretion of complement component C3 by resident, elicited and activated macrophages. Comparison with C2, C4 and lysosomal enzyme release.
Zimmer B; Hartung HP; Scharfenberger G; Bitter-Suermann D; Hadding U
Eur J Immunol; 1982 May; 12(5):426-30. PubMed ID: 7094993
[TBL] [Abstract][Full Text] [Related]
30. Effect of histamine on the gene expression and biosynthesis of complement components C2, factor B and C3 in mouse peritoneal macrophages.
Falus A; Meretey K
Immunology; 1987 Apr; 60(4):547-51. PubMed ID: 3646991
[TBL] [Abstract][Full Text] [Related]
31. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. I. Generation of the activated complex.
Miyama A; Kato T; Horai S; Yokoo J; Kashiba S
Biken J; 1975 Dec; 18(4):193-204. PubMed ID: 1218074
[TBL] [Abstract][Full Text] [Related]
32. Biosynthesis of C4 by mouse peritoneal macrophages. II. Comparison of C4 synthesis by resident and elicited cell populations.
Newell SL; Atkinson JP
J Immunol; 1983 Feb; 130(2):834-8. PubMed ID: 6336772
[TBL] [Abstract][Full Text] [Related]
33. Interaction of C3b, B, and D in the alternative pathway of complement activation.
Nicholson A; Brade V; Schorlemmer HU; Burger R; Bitter-Suermann D; Hadding U
J Immunol; 1975 Oct; 115(4):1108-13. PubMed ID: 240884
[TBL] [Abstract][Full Text] [Related]
34. Complement activation in semisolid media: insolubilization of alternative pathway convertases in agar gels with C3 nephritic factor-containing sera.
Arnaout MA; Davis AE; Rosen RS; Alper CA
J Immunol; 1977 Oct; 119(4):1316-20. PubMed ID: 894039
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo augmentation by muroctasin of the production of the third component of complement by murine macrophages.
Endo N
Arzneimittelforschung; 1988 Jul; 38(7A):993-6. PubMed ID: 3190805
[TBL] [Abstract][Full Text] [Related]
36. Molecular regulation of MHC class III (C4 and factor B) gene expression in mouse peritoneal macrophages.
Sackstein R; Colten HR
J Immunol; 1984 Sep; 133(3):1618-26. PubMed ID: 6205089
[TBL] [Abstract][Full Text] [Related]
37. Alternative pathway complement activation in rheumatoid arthritis.
El-Ghobarey A; Whaley K
J Rheumatol; 1980; 7(4):453-60. PubMed ID: 6158571
[TBL] [Abstract][Full Text] [Related]
38. Control of complement synthesis and secretion in bronchoalveolar and peritoneal macrophages.
Cole FS; Matthews WJ; Marino JT; Gash DJ; Colten HR
J Immunol; 1980 Sep; 125(3):1120-4. PubMed ID: 6997377
[TBL] [Abstract][Full Text] [Related]
39. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
Densen P; McRill CM; Ross SC
J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
[TBL] [Abstract][Full Text] [Related]
40. T- and B-cell-independent activation of syngeneic macrophages by murine sarcoma cells.
Olstad R; Gaudernack G; Kaplan G; Seljelid R
Cancer Res; 1980 Jun; 40(6):2054-60. PubMed ID: 6966185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
